Study directory

Schizophrenia studies

Compare studies and check their requirements with the research team.

Back to overview
More filters: keywords, city, remote
4306studies shown
Showing 1,057-1,068 of 4,306
Drug study icon
TerminatedNCT03121586

Extension Study of Pimavanserin for the Adjunctive Treatment of Schizophrenia

This summary needs review. Please check the official study record and contact the research team for details.

Multiple locations, including Phoenix
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugA study involving a medication or substance.Over 18 Years
Countries
United States, Canada, Argentina, ...
Sponsor
ACADIA Pharmaceuticals Inc.
Condition
Schizophrenia
Drug study icon
CompletedNCT02600741

Family Intervention in Recent Onset Schizophrenia Treatment (FIRST)

This summary needs review. Please check the official study record and contact the research team for details.

Multiple locations, including Bullhead City
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugOver 18 Years
Countries
United States
Sponsor
Janssen Scientific Affairs, LLC
Condition
Schizophrenia
Drug study icon
CompletedNCT00304473

Fast Titration in the Treatment of Schizophrenia, Taiwan

This summary needs review. Please check the official study record and contact the research team for details.

In Taoyuan
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugOver 18 Years
Countries
Taiwan
Sponsor
AstraZeneca
Condition
Schizophrenia
Drug study icon
CompletedNCT00254813

Fast Titration Of Quetiapine Versus Currently Approved Titration

This summary needs review. Please check the official study record and contact the research team for details.

Multiple locations, including Arendal
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugFrom 18 Years to 60 Years
Countries
Norway
Sponsor
AstraZeneca
Condition
Schizophrenia
Drug study icon
CompletedNCT01190254

Asenapine for schizophrenia

This study is completed. It is testing asenapine for schizophrenia.

Location not clearly listed
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugFrom 12 Years to 17 Years
Countries
Sponsor
Organon and Co
Condition
Schizophrenia
Other study type icon
TerminatedNCT03040505

Future Mental Projections in Schizophrenia

This summary needs review. Please check the official study record and contact the research team for details.

In Strasbourg
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaObservationalA study where researchers collect information without assigning a treatment.From 18 Years to 55 Years
Countries
France
Sponsor
University Hospital, Strasbourg, France
Condition
Schizophrenia
Drug study icon
CompletedNCT05258123

Ginkgo Biloba Extract in the Treatment of Schizophrenia

This summary needs review. Please check the official study record and contact the research team for details.

In Beijing
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugFrom 18 Years to 60 Years
Countries
China
Sponsor
Beijing HuiLongGuan Hospital
Condition
Schizophrenia
Drug study icon
CompletedNCT01569659

High Dose Lurasidone for people with Treatment Resistant Schizophrenia

This summary needs review. Please check the official study record and contact the research team for details.

In Chicago
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugFrom 18 Years to 60 Years
Countries
United States
Sponsor
Northwestern University
Condition
Schizophrenia
Device study icon
CompletedNCT01022489

High Frequency Repetitive Transcranial Magnetic Stimulation (rTMS) in Schizophrenia : a Controlled Study

This study is completed in France. It is testing high Frequency Repetitive Transcranial Magnetic Stimulation for schizophrenia.

In Caen
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDeviceA study involving a tool, app, wearable, test, or medical device.From 16 Years to 65 Years
Countries
France
Sponsor
University Hospital, Caen
Condition
Schizophrenia
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.